Other congenital malformations of respiratory system

Q17_OTHER_CONGEN_MALFO_RESPI_SYSTEM

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Q34 Cause of death: ICD-10 — Q34 2 out of 7 registries used, show all original rules.	65
4. Check minimum number of events None	65
5. Include endpoints None	65
6. Filter based on genotype QC (FinnGen only)	64

Control definitions (FinnGen only)

Control exclude: Q17_CONGEN_MALFO_RESPI_SYSTEM

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: Q3[0-4]
Name in latin: Aliae malformationes congenitae systematis respiratorii

NAME	Q17_OTHER_CONGEN_MALFO_RESPI_SYSTEM
CONTROL_EXCLUDE	Q17_CONGEN_MALFO_RESPI_SYSTEM
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Q34
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Q34
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other congenital malformations of respiratory system based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	457	225	232
Only index persons	393	196	197
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	-	43.31	33.85
Only index persons	45.30	46.54	44.08

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	64	37	27
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	42.89	43.79	41.65

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
65: Matched controls
650

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Q34.1

ICD-10 Finland

Congenital cyst of mediastinum

+∞

50.8

Q34.0

ICD-10 Finland

Anomaly of pleura

+∞

12.9

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

11.5

10.6

UGC12

NOMESCO Finland

Flexible bronchoscopy

13.9

10.0

GEB30

NOMESCO Finland

Mediastinotomy and excision of lesion

+∞

7.4

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

+∞

7.4

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.9

6.7

174

Q34.88

ICD-10 Finland

Other specified congenital malformations of respiratory system

+∞

6.3

Q33.08

ICD-10 Finland

Congenital cystic lung

+∞

6.3

R4110

NOMESCO Finland

Physiotherapy

3.7

6.3

135

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.8

6.2

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

4.3

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3000991) Gas panel - Venous blood

4.80

6.63

9.7

6.5

—

(3042936) Bacteria identified in Isolate by Culture

4.02

5.87

1.3

2.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4.23

5.66

2.5

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4.23

5.66

2.5

1.8

—

(3000494) Fungus identified in Specimen by Culture

4.14

5.52

1.2

1.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3.87

5.40

2.7

2.0

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

3.98

5.24

6.9

9.6

104.00

104.49

mmol/l

0.21

(40768797) Stomach Pathology biopsy report

3.51

4.39

1.3

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

6.74

4.32

2.4

2.3

—

(3022217) INR in Platelet poor plasma by Coagulation assay

187

2.89

4.25

10.9

10.8

1.18

1.19

inr

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

112

3.00

4.16

2.7

—

(3012544) pH of Venous blood

3.53

4.08

6.1

8.4

—

(3023368) Bacteria identified in Blood by Culture

123

2.86

3.89

6.3

4.6

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2.99

3.68

4.4

3.5

17.73

75.25

ng/l

0.85

(3020682) Albumin/Creatinine [Ratio] in Urine

127

2.75

3.63

3.9

3.5

6.88

10.66

mg/mmol

0.36

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

10.84

3.57

1.5

1.3

—

(3044889) 12 lead EKG panel

352

3.08

3.56

3.8

3.3

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

4.94

3.48

8.6

8.9

0.85

1.36

—

(3014007) Fractional oxyhemoglobin in Arterial blood

4.94

3.48

8.6

9.0

94.57

94.15

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

4.94

3.48

8.3

8.9

0.55

0.75

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

6.34

3.46

1.3

1.8

—

(3006315) Basophils [#/volume] in Blood

266

2.64

3.41

9.7

8.0

0.04

e9/l

0.05

231

(3001604) Monocytes [#/volume] in Blood

267

2.62

3.37

9.7

8.0

0.53

0.58

e9/l

0.90

233

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

9.28

3.33

1.0

—

(3000492) Spirometry study

3.36

3.24

1.9

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

261

2.55

3.23

10.8

8.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

174

2.49

3.19

4.7

3.6

2.34

2.36

mmol/l

0.43

158

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

4.35

3.13

2.7

1.6

—

(3002256) Pathology report gross observation

3.16

3.12

1.2

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

8.11

3.12

3.5

5.0

37.83

41.15

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

8.11

3.12

1.2

1.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

8.11

3.12

2.5

1.7

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

8.11

3.12

1.2

1.0

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

184

2.46

3.11

7.9

3.0

—

(3013115) Eosinophils [#/volume] in Blood

274

2.51

3.09

10.6

8.9

0.15

0.19

e9/l

0.97

241

(3019198) Lymphocytes [#/volume] in Blood

274

2.51

3.09

9.7

7.9

2.02

2.09

e9/l

0.14

245

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

237

2.45

3.08

2.9

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

10.67

3.03

1.2

—

(3012516) Albumin [Mass/volume] in Urine

123

2.51

2.96

3.0

3.2

40.94

566.18

mg/l

0.53

(3011397) Hemoglobin [Presence] in Urine by Test strip

123

2.51

2.96

3.8

2.9

—

(3022948) Iron [Moles/volume] in Serum or Plasma

2.73

2.94

3.4

2.3

14.22

14.76

umol/l

0.07

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

5.46

2.81

1.1

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

8.89

2.79

1.2

1.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

8.89

2.79

3.8

8.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

4.18

2.79

7.9

9.5

—

(3052851) Hemolysis interference index of Serum or Plasma

6.48

2.76

2.5

2.7

—

(3044640) Blood type and Crossmatch panel - Blood

151

2.35

2.72

3.5

2.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

5.09

2.67

1.3

1.7

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2.66

2.60

3.7

2.2

2.14

2.55

g/l

1.81

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

3.85

2.59

7.9

4.0

29.26

99.63

u/ml

—

(3018418) pH of Serum or Plasma

138

2.32

2.57

6.7

3.6

7.37

7.42

—

(3009508) Creatinine [Moles/volume] in Urine

146

2.30

2.57

4.3

2.8

7.78

8.15

mmol/l

0.13

134

(3044290) Cell count panel - Cerebral spinal fluid

4.76

2.55

1.9

4.5

—

(3022096) Basophils/100 leukocytes in Blood

251

2.24

2.53

10.8

7.9

0.63

0.67

0.16

236

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2.65

2.47

3.9

2.3

27.62

24.45

0.20

(40758558) Short blood count panel - Blood

141

2.26

2.43

17.6

8.8

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

312

2.27

2.42

17.8

12.3

4.00

3.80

e9/l

0.19

267

(3023520) Reticulocytes [#/volume] in Blood

3.10

2.42

3.2

5.2

75.27

77.16

e9/l

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

6.65

2.41

1.4

1.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

3.43

2.33

1.7

1.2

—

(4035726) Immunohistochemistry procedure

3.43

2.33

1.8

1.2

—

(3006504) Eosinophils/100 leukocytes in Blood

257

2.15

2.32

10.9

8.0

2.31

2.85

1.15

241

(3030467) Casts [#/volume] in Urine by Automated count

144

2.20

2.29

9.2

2.9

0.16

0.30

e6/l

0.42

106

(3019069) Monocytes/100 leukocytes in Blood

258

2.14

2.29

10.9

8.3

8.56

8.34

0.20

244

(40768804) Tissue Pathology biopsy report

186

2.14

2.28

2.3

1.7

—

(3016018) Differential panel - Cerebral spinal fluid

5.91

2.25

1.8

5.8

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

4.60

2.20

1.2

1.6

—

(3037467) Urinalysis macro (dipstick) panel - Urine

340

2.21

2.18

8.0

4.0

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3.20

2.17

1.3

1.9

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2.35

2.14

6.3

2.5

9.00

1.35

e6/l

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

173

2.09

2.12

2.7

1.9

97.14

101.62

pmol/l

0.16

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

5.31

2.11

1.2

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

5.31

2.11

1.2

1.6

—

(3023410) Appearance of Cerebral spinal fluid

5.31

2.11

1.8

6.4

—

(36304419) Bacteria [Presence] in Urine

150

2.08

2.03

9.2

2.9

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3.00

2.02

1.7

1.3

—

(3002030) Lymphocytes/100 leukocytes in Blood

267

2.02

1.99

10.9

8.0

28.30

30.45

0.46

252

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

4.02

1.98

1.0

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

4.02

1.98

1.3

7.9

3.62

3.28

g/l

—

(3031040) Bacteria [#/volume] in Urine by Automated count

319

2.03

1.90

8.4

4.1

—

29.71

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2.26

1.90

6.2

2.5

2.47

2.45

mmol/l

0.33

(3019060) Gas panel - Arterial blood

3.00

1.86

2.8

4.8

—

(3037522) Nuclear Ab [Titer] in Serum

2.27

1.75

1.1

1.5

—

429.47

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2.09

1.67

6.2

2.5

0.43

0.93

e6/l

—

(3021589) Normoblasts [#/volume] in Blood

242

1.85

1.61

15.7

11.5

0.01

0.00

e9/l

0.48

195

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

3.52

1.55

1.2

2.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2.66

1.55

1.3

1.5

—

(3002582) Erythrocytes [#/volume] in Urine

163

1.87

1.54

9.4

2.9

25.96

19.76

e6/l

0.20

128

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2.45

1.47

4.4

2.0

—

(3007164) IgA [Mass/volume] in Serum or Plasma

115

1.92

1.45

1.8

1.6

1.74

2.30

g/l

1.37

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

3.10

1.38

1.6

1.3

1.12

1.11

g/l

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.27

1.37

20.2

13.4

24.21

24.45

mmol/l

—

(36660697) Celiac disease serology panel - Serum

2.20

1.37

1.4

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2.54

1.35

2.9

1.9

—

(3018095) Leukocytes [#/volume] in Urine

187

1.76

1.34

11.4

3.5

19.21

21.14

e6/l

0.07

134

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2.76

1.24

1.8

6.6

159.80

166.00

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

2.76

1.24

1.0

0.00

g/l

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

2.76

1.24

1.0

0.00

g/l

—

(3021601) Nitrite [Presence] in Urine by Test strip

247

1.68

1.22

8.4

4.9

0.00

estimate

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2.44

1.21

1.0

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2.62

1.17

1.6

6.6

90.20

90.30

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2.62

1.17

1.0

35.38

39.18

g/l

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2.62

1.17

1.0

11.60

11.24

g/l

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

2.62

1.17

1.0

1.1

0.00

g/l

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

2.49

1.11

1.0

1.1

0.00

1.26

g/l

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2.37

1.05

1.6

12.1

0.44

0.69

—

(3026008) Bacteria identified in Urine by Culture

140

1.62

0.91

5.1

2.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

2.10

0.89

1.2

2.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

116

1.63

0.85

2.0

1.6

20.71

23.98

nmol/l

0.51

105

(3035350) Ketones [Presence] in Urine by Test strip

254

1.51

0.84

6.3

3.3

0.00

estimate

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

471

1.68

0.82

26.5

11.5

91.33

86.80

ml/min/173m2

0.80

381

(46235355) HIV 1 and 2 tests - Meaningful Use set

109

1.62

0.81

3.0

2.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.77

0.79

1.7

1.9

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2.27

0.78

1.0

1.3

3.86

2.84

g/l

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2.17

0.76

1.0

1.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2.17

0.76

1.0

1.3

9.64

7.60

g/l

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2.17

0.76

1.0

1.3

4.20

3.88

g/l

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.52

0.73

2.2

1.8

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1.92

0.70

4.4

12.7

135.00

125.37

g/l

—

(1002224) Polysomnography panel

1.85

0.67

1.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.78

0.65

1.0

1.4

—

(3022313) Gas panel - Capillary blood

1.72

0.62

24.8

6.3

—

(40761535) Cells panel - Urine sediment

1.84

0.60

2.3

2.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

0.00

0.60

0.0

1.6

—

345.28

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.58

0.57

1.8

1.7

—

(3013512) EKG study

125

0.68

0.49

2.7

3.5

—

(3016879) Cocaine [Presence] in Urine

1.66

0.44

1.2

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.43

0.43

4.5

5.8

—

(3003694) ABO and Rh group [Type] in Blood

162

1.34

0.42

1.5

1.6

—

(3027944) Amphetamines [Presence] in Urine

1.56

0.42

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

0.00

0.42

0.0

1.7

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.2

—

0.26

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.41

0.41

1.5

1.6

—

(3028300) Cannabinoids [Presence] in Urine

1.51

0.41

1.2

—

(3027008) Opiates [Presence] in Urine

1.51

0.41

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

1.51

0.41

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.40

0.0

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.40

0.0

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.40

0.0

1.2

—

(40761536) Microorganisms panel - Urine sediment

1.46

0.40

13.2

3.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.46

0.39

1.3

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

136

1.34

0.39

1.6

1.7

—

(3029937) Albumin [Presence] in Urine by Test strip

129

1.32

0.34

6.1

3.2

0.00

estimate

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.23

0.26

2.2

1.7

—

(1761868) Lipid panel - Serum or Plasma

202

1.21

0.25

2.2

2.4

—

(4200892) Spirometry reversibility

1.27

0.23

1.2

1.3

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.06

—

(40760888) Immunoglobulin light chains.free panel - Serum

0.00

0.21

0.0

2.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.21

0.0

5.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

0.21

0.0

2.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

0.00

0.20

0.0

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1.25

0.19

4.9

3.4

16.82

20.90

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.14

0.16

1.2

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

195

1.11

0.09

5.2

3.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.10

0.08

2.3

2.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

413

1.05

0.01

4.5

3.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

164

1.05

0.00

3.8

3.4

18.01

38.87

ng/l

—

(3041096) Erythrocytes [Presence] in Urine by Automated

145

1.04

0.00

6.3

3.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.0

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.0

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.0

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.0

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.0

1.2

—

(3036180) Methadone [Presence] in Urine

0.00

0.0

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

0.0

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.0

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.0

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.5

—

(3034988) Calcium [Moles/volume] in Capillary blood

0.00

0.0

2.3

—

1.21

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

-0.00

0.0

2.8

—

108.20

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

0.00

-0.00

0.0

1.6

—

9.16

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

149.53

—

(3022145) Colonoscopy Study observation

0.98

-0.00

1.2

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.00

-0.00

0.0

3.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

-0.00

0.0

1.0

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

4.6

—

4.17

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

0.99

-0.00

1.2

1.8

437.26

510.89

pmol/l

—

(3038515) Glucose [Moles/volume] in Venous blood

0.00

-0.00

0.0

2.9

—

5.73

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

-0.00

0.0

2.8

—

3.92

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

-0.00

0.0

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

-0.00

0.0

1.0

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

-0.00

0.0

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

-0.00

0.0

1.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

-0.00

0.0

2.8

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint Q17_OTHER_CONGEN_MALFO_RESPI_SYSTEM and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have Q17_OTHER_CONGEN_MALFO_RESPI_SYSTEM.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: Q17_OTHER_CONGEN_MALFO_RESPI_SYSTEM – Other congenital malformations of respiratory system

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other congenital malformations of respiratory system

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints